Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders

Kelley-Seegmiller syndrome

The disease is caused by a partial deficiency of the enzyme hypoxanthine phosphoribosyltransferase 1 encoded by the gene HPRT, which results in uric acid accumulation. The clinical picture is characterized by gout and uric acid kidney stones.

Systematic

Uric acid nephropathy
Hyperuricemic nephropathy
Kelley-Seegmiller syndrome
HPRT1
Lesch-Nyhan syndrome
Renal Hypouricemia

References:

1.

Kelley WN et al. (1967) A specific enzyme defect in gout associated with overproduction of uric acid.

[^]
2.

McDonald JA et al. (1971) Lesch-Nyhan syndrome: altered kinetic properties of mutant enzyme.

[^]
3.

Yü TF et al. (1972) Rarity of X-linked partial hypoxanthine-guanine phosphoribosyltransferase deficiency in a large gouty population.

[^]
4.

Zoref-Shani E et al. (2000) Kelley-Seegmiller syndrome due to a unique variant of hypoxanthine-guanine phosphoribosyltransferase: reduced affinity for 5-phosphoribosyl-1-pyrophosphate manifested only at low, physiological substrate concentrations.

[^]
5.

Srivastava T et al. (2002) Childhood hyperuricemia and acute renal failure resulting from a missense mutation in the HPRT gene.

[^]
6.

Andrés A et al. (1987) Partial deficit of hypoxanthine guanine phosphoribosyl transferase presenting as acute renal failure.

[^]
7.

Orphanet article

Orphanet ID 79233 [^]
8.

OMIM.ORG article

Omim 300323 [^]
9.

Wikipedia article

Wikipedia EN (Lesch–Nyhan_syndrome) [^]
Update: April 29, 2019